Human genetic basis of coronavirus disease 2019

H Deng, X Yan, L Yuan - Signal transduction and targeted therapy, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in considerable …

Exercise, immune system, nutrition, respiratory and cardiovascular diseases during COVID-19: a complex combination

O Scudiero, B Lombardo, M Brancaccio… - International Journal of …, 2021 - mdpi.com
Coronaviruses (CoVs) represent a large family of RNA viruses that can infect different living
species, posing a global threat to human health. CoVs can evade the immune response …

Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre/Pro-biotics in manipulating microflora

KS Alharbi, Y Singh, S Rawat, O Afzal… - Chemico-biological …, 2022 - Elsevier
Abstract Coronavirus disease (COVID-19), a coronavirus-induced illness attributed to severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, is thought to have …

Trace elements as immunoregulators in SARS-CoV-2 and other viral infections

K Dharmalingam, A Birdi, S Tomo… - Indian Journal of Clinical …, 2021 - Springer
Nutritional deficiency is associated with impaired immunity and increased susceptibility to
infections. The complex interactions of trace elements with the macromolecules trigger the …

Synthetic peptides that antagonize the angiotensin-converting enzyme-2 (ACE-2) interaction with SARS-CoV-2 receptor binding spike protein

A Sadremomtaz, ZM Al-Dahmani… - Journal of medicinal …, 2021 - ACS Publications
The SARS-CoV-2 viral spike protein S receptor-binding domain (S-RBD) binds ACE2 on
host cells to initiate molecular events, resulting in intracellular release of the viral genome …

Biomarkers during COVID-19: mechanisms of change and implications for patient outcomes

CH Chen, SW Lin, CF Shen, KS Hsieh, CM Cheng - Diagnostics, 2022 - mdpi.com
As the COVID-19 (Coronavirus disease 19) pandemic spreads worldwide, the massive
numbers of COVID-19 patients have created a considerable healthcare burden for every …

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now

MA Mohammed - Frontiers in Pharmacology, 2023 - frontiersin.org
A novel coronavirus strain (COVID-19) caused severe illness and mortality worldwide from
31 December 2019 to 21 March 2023. As of this writing, 761,071,826 million cases have …

[HTML][HTML] Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

SA Thair, YD He, Y Hasin-Brumshtein, S Sakaram… - Iscience, 2021 - cell.com
The pandemic 2019 novel coronavirus disease (COVID-19) shares certain clinical
characteristics with other acute viral infections. We studied the whole-blood transcriptomic …

Traditional uses, pharmacological effects, and molecular mechanisms of licorice in potential therapy of COVID-19

Q Zhang, H Huang, M Qiu, Z Wu, Z Xin, X Cai… - Frontiers in …, 2021 - frontiersin.org
The current Coronavirus disease 2019 (COVID-19) pandemic has become a global
challenge, and although vaccines have been developed, it is expected that mild to moderate …

[HTML][HTML] Carotenoids: Therapeutic strategy in the battle against viral emerging diseases, COVID-19: An overview

A Khalil, D Tazeddinova, K Aljoumaa… - … nutrition and food …, 2021 - ncbi.nlm.nih.gov
Carotenoids, a group of phytochemicals, are naturally found in the Plant kingdom,
particularly in fruits, vegetables, and algae. There are more than 600 types of carotenoids …